Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 |
| | 8-K | 8-K | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Spring Powered | | | | | | 4.4 | | |
| Vial Adapters | | | | | | 0.6 | | |
| License and Technology Fees | | | | | | 0.7 | | |
| Other | | | | | | 0.8 | | |
| Total revenues [+] | 1.8 | 1.5 | 2.0 | 5.6 | 6.7 | 6.5 | 8.3 | 10.8 |
| Products | 1.8 | 1.5 | 2.0 | | | | | |
| Revenue growth | 19.3% | -21.7% | | -16.7% | 3.4% | -22.5% | -22.7% | -12.1% |
| Cost of goods sold | 2.7 | 2.5 | 3.0 | 2.0 | 1.9 | 0.0 | 0.0 | 0.0 |
| Gross profit | -0.9 | -1.0 | -1.0 | 3.5 | 4.7 | 6.5 | 8.3 | 10.8 |
| Gross margin | -49.7% | -63.3% | -52.3% | 63.3% | 70.9% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | -0.2 | 0.0 | 0.0 | 2.0 | 1.9 | 2.6 | 3.2 | 4.8 |
| Research and development | | | | | | | | |
| Other operating expenses | 0.2 | 0.0 | 0.0 | 3.2 | 3.7 | 6.4 | 9.0 | 12.4 |
| EBITDA [+] | | | | -1.1 | -0.2 | -1.7 | -2.9 | -4.9 |
| EBITDA growth | -6.4% | -5.2% | | 424.4% | -86.9% | -42.5% | -40.9% | -1.8% |
| EBITDA margin | -49.7% | -63.3% | -52.3% | -20.3% | -3.2% | -25.5% | -34.4% | -45.1% |
| Depreciation and amortization | | | | 0.6 | 0.7 | 0.8 | 1.0 | 1.5 |
| EBIT [+] | -0.9 | -1.0 | -1.0 | -1.7 | -0.9 | -2.5 | -3.9 | -6.4 |
| EBIT growth | -6.4% | -5.2% | | 90.9% | -64.6% | -35.5% | -39.5% | 4.7% |
| EBIT margin | -49.7% | -63.3% | -52.3% | -30.3% | -13.2% | -38.6% | -46.4% | -59.4% |
| Interest expense, net [+] | | | | 0.0 | 0.2 | 0.5 | 0.5 | 1.7 |
| Interest expense | | | | 0.0 | 0.2 | 0.5 | 0.6 | 1.9 |
| Interest income | | | | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 |
| Other income (expense), net | -0.2 | -0.2 | -0.2 | 0.2 | 0.0 | -0.1 | 0.4 | 1.1 |
| Pre-tax income | -1.1 | -1.1 | -1.2 | -1.5 | -1.1 | -3.0 | -4.0 | -7.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -1.1 | -1.1 | -1.2 | -1.6 | -1.1 | -3.3 | -4.4 | -7.3 |
| Net margin | -62.5% | -74.1% | -61.0% | -28.2% | -16.9% | -50.3% | -53.1% | -67.9% |
| |
| Basic EPS [+] | ($0.04) | ($0.06) | | | | | | |
| Growth | -33.3% | | | | | | | |
| Diluted EPS [+] | ($0.04) | ($0.06) | | | | | | |
| Growth | -33.3% | | | | | | | |
| |
| Shares outstanding (basic) [+] | 28.5 | 18.9 | | | | | | |
| Growth | 51.1% | | | | | | | |
| Shares outstanding (diluted) [+] | 28.5 | 18.9 | | | | | | |
| Growth | 51.1% | | | | | | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|